[ Price : $8.95]
FDA issues Valeant Pharmaceuticals a complete response letter for an NDA for Potiga (ezogabine), an investigational anti-epileptic...[ Price : $8.95]
FDA grants Octapharma USA fast track status on its investigational drug Octaplex as a treatment for reversing anticoagulation ther...[ Price : $8.95]
Workshop participants looking at how health literacy can promote safer drug use say FDA needs to take a more active role in a numb...[ Price : $8.95]
FDA clears Quest Diagnostics Simplexa molecular flu test.[ Price : $8.95]
CDRH director Jeffrey Shuren dismisses a recent study on device approval delays, calling it highly flawed with its inadequate samp...[ Price : $8.95]
California Stem Cell files an IND with FDA to begin a Phase 1 safety study for a stem cell-derived therapy to treat Spinal Muscula...[ Price : $8.95]
FDA approves a shorter dosing time for Cubicin for treating MRSA.[ Price : $8.95]
Members of FDAs Oncologic Drugs Advisory Committee vote not to recommend expanding use of GlaxoSmithKlines Avodart (dutasteride) a...